VaccImm

VaccImm simulates peptide vaccination and immune–tumor interactions using an agent-based model to evaluate immunogenicity and treatment parameters in cancer therapy.

Key Features:

• Agent-Based Modeling: Employs an agent-based model that simulates interactions among immune cells (including T cells), cancer cells, antibodies, antigens, and semiochemicals.
• Molecular Representation: Represents molecular binding sites on immune cells using real amino acid sequences to reflect biologically realistic binding interactions.
• Time-Resolved Population Statistics: Generates detailed statistics of population sizes and states of individual cell types over time.
• Parameter Space Exploration: Enables in silico exploration of vaccination parameters, including the number of epitopes, to assess their impact on immune response.

Scientific Applications:

• Modeling Immune–Tumor Dynamics: Simulates dynamics of T cells, cancer cells, antibodies, antigens, and semiochemicals to study mechanisms of peptide vaccination.
• Vaccine Parameter Optimization: Explores parameter space in silico to evaluate effects of epitope number and other variables on vaccination efficacy.
• Experimental Design and Protocol Optimization: Provides time-resolved population statistics to inform experimental setups and optimize therapeutic protocols.

Methodology:

Uses an agent-based computational model with molecular binding sites represented by real amino acid sequences, records time-series statistics of cell populations and states, and supports in silico parameter exploration.